Avoid increasing doses on your own, as this may increase side effects and affect refill approval
This explains why Tirzepatide produces approximately 40% more weight loss than Semaglutide despite both activating GLP-1 receptors
Top with lean proteins such as beans, fish, eggs, or tofu
Half-life for Retatrutide runs approximately 6 days, slightly longer than Tirzepatide
Since most glucose-dependent insulinotropic polypeptide (GIP) receptor: glucagon-like peptide- 1 receptor (GLP- 1) receptor: glucagon receptor triagonists compete in efficacy with bariatric surgery, the success of these agents in preclinical models and clinical trials suggests a bright future for multi-agonists in the treatment of metabolic diseases
Medicare prohibits the coverage of prescription weight-loss drugs, and only 1% of seniors said that they have used a GLP-1 drug solely for weight loss, according to the KFF survey